Sight Diagnostics - About the company
Sight Diagnostics is a series D company based in Jerusalem (Israel), founded in 2011 by Yossi Pollak. It operates as a Platform for blood analysis and infectious disease diagnostics based on its computer vision technology. Sight Diagnostics has raised $124M in funding from investors like Longliv Ventures, OurCrowd and GEOC. The company has 8 active competitors, including 2 that are funded. Its top competitors include companies like Bertis, Sciverse and Audosens.
Company Details
Sight Diagnostics developed a platform for blood analysis and infectious disease diagnostics based on its computer vision technology. Its platform is built on sample preparation, biological staining, machine-vision algorithms, and clinical instrumentation, to provide diagnostic solutions that are suitable for point-of-care use. Its first product, the Parasight Malaria Detection platform, identifies, enumerates, and speciates malarial parasites.Currently, it is applying its technology to the $20 billion complete blood count (CBC) market, developing a point-of-care CBC platform which will provide a 5 point differential blood count is expected in the summer 2016.
- Website
- www.sightdx.com/
- Email ID
- *****@sightdx.com
- Registered Address
- MAZARS,30 OLD BAILEY,LONDON,UNITED KINGDOM,EC4M 7AU
Key Metrics
Founded Year
2011
Location
Jerusalem, Israel
Stage
Series D
Total Funding
$124M in 4 rounds
Latest Funding Round
Investors
Ranked
2nd among 8 active competitors
Employee Count
62 as on Jul 31, 2026
Similar Companies
Legal entities associated with Sight Diagnostics
Sight Diagnostics is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
SIGHT DIAGNOSTICS UK LIMITED CIN: 12077028 , United Kingdom, Active | Jun 30, 2019 | £1M - £10M (As on Dec 31, 2020) | 10 (As on Dec 31, 2020) |
Sign up to download Sight Diagnostics' company profile
Sight Diagnostics's funding and investors
Sight Diagnostics has raised a total funding of $124M over 4 rounds. Its latest funding round was a Series D round on Jul 26, 2020 for $*****. 4 investors participated in its latest round. Sight Diagnostics has 15 institutional investors and 4 angel investors.
Here is the list of recent funding rounds of Sight Diagnostics:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 26, 2020 | 7374333 | Series D | 9765694 | 7179077 | 7778148 | 5697430 |
Dec 2018 | 9212206 | Series C | 9143502 | 7056712 | 2211006 | |
Apr 08, 2014 | 3594366 | Series B | 8650658 | 1082149 | 6112187 | 7437779 |
View details of Sight Diagnostics's funding rounds and investors
Sight Diagnostics' founders and board of directors
Founder? Claim ProfileThe founders of Sight Diagnostics is Yossi Pollak.
Here are the details of Sight Diagnostics' key team members:
- Yossi Pollak: Co-Founder & CEO of Sight Diagnostics and founder of 1 other company. Contact Info: 1 email address
View details of Sight Diagnostics's Founder profiles and Board Members
Sight Diagnostics' employee count trend
Sight Diagnostics has 62 employees as of Jul 26. Here is Sight Diagnostics's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Sight Diagnostics's Competitors and alternates
Top competitors of Sight Diagnostics include Bertis, Sciverse and Audosens. Here is the list of Top 10 competitors of Sight Diagnostics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Bertis 2014, Seongnam-si (South Korea), Series B | Developer of AI-based diagnostic platform for cancer and cardiac diseases | $13.5M | 48/100 | |
2nd | Sight Diagnostics 2011, Jerusalem (Israel), Series D | Platform for blood analysis and infectious disease diagnostics based on its computer vision technology | $124M | 47/100 | |
3rd | Developer of AI-driven point-of-care diagnostic and software technologies | - | - | 35/100 | |
4th | Provider of a diagnostic device for optical detection of multiple analytes | - | 34/100 | ||
5th | Provider of non invasive tissue oxygenation monitoring devices | - | 27/100 | ||
6th | SDG3 Health 2020, India, Unfunded | AI based & non invasive anemia screening application | - | - | 16/100 |
7th | AI-powered software for diagnosing and predicting various health conditions | - | - | 16/100 | |
8th | Provider of non-invasive health biomarker testing from human sweat | - | - | 15/100 |
Looking for more details on Sight Diagnostics's competitors? Click here to see the top ones
Sight Diagnostics's Investments and acquisitions
Sight Diagnostics has made no investments or acquisitions yet.
News related to Sight Diagnostics
•
Sight Diagnostics® and Inter Medico Announce the Health Canada Approval of Sight OLO for Point-of-Care TestingCNW•Jan 11, 2022•Sight Diagnostics
•
Sight Diagnostics Expands to Nordics and Baltics, Bringing AI-Powered, Fingerprick Blood Testing To Eight More Countries in EuropeWebwire•Nov 04, 2021•Sight Diagnostics
•
Sight Diagnostics Named to CNBC Disruptor 50 List After Year of Tremendous Momentum in Scaling its AI-Powered Sight OLO Blood AnalyzerWebwire•May 25, 2021•Sight Diagnostics
•
Sight Diagnostics Expands to Canada through a Distribution Partnership with Inter MedicoWebwire•Apr 22, 2021•Sight Diagnostics, Inter Medico
•
Sight Diagnostics Expands to the Gulf Region through a Distribution Partnership with Phoenix CapitalMedical Device News•Dec 09, 2020•Sight Diagnostics, Phoenix Capital
•
Sight Diagnostics, Phoenix Capital Ink Distribution Deal in Middle East for Point-of-Care Analyzers360Dx•Dec 09, 2020•Sight Diagnostics, Phoenix Capital, Phoenix Capital, Phoenix Capital Group
•
Sight Diagnostics raises $71 million amidst Covid-19 demand for blood count devicesCTech•Jul 26, 2020•Sight Diagnostics, IFC, Koch Industries, OurCrowd and 4 others
•
U.S. FDA clears Israeli startup Sight Diagnostics' finger prick blood testReuters•Dec 04, 2019•Sight Diagnostics
•
Sight Diagnostics Announces Strategic Hires to Expand US and Global Presence, Bringing Improved Blood Testing to MillionsWebwire•Sep 23, 2019•Sight Diagnostics
•
Sight Diagnostics – “OLO” AI Based Fastest Blood Testing DeviceBioTecNika•Mar 08, 2019•Sight Diagnostics
Are you a Founder ?
FAQs about Sight Diagnostics
Explore our recently published companies
- Seededge Solutions - Pune based, Unfunded company
- Secuarden AI - Melbourne based, 2026 founded, Unfunded company
- Secretair AI - France based, 2025 founded, Unfunded company
- Second Loop AI - Unfunded company
- Seawin AI - Unfunded company
- Seamless IT AI - United States based, Unfunded company